Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Immunoscore®
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Veracyte
Type:
CE Marked
Related tests:
‹
Prosigna™ Breast Cancer Prognostic Gene Signature Assay (3)
Afirma® Genomic Sequencing Classifier
Brightplex® MDSC Assay
C2inform test
Decipher Bladder Test
Decipher Prostate Cancer Test
Immunoscore® IC Assay
Immunoscore® TCE test
LymphMark™ Assay
Prosigna™ Breast Cancer Prognostic Gene Signature Assay (3)
Afirma® Genomic Sequencing Classifier
Brightplex® MDSC Assay
C2inform test
Decipher Bladder Test
Decipher Prostate Cancer Test
Immunoscore® IC Assay
Immunoscore® TCE test
LymphMark™ Assay
›
Details
Evidence
News
Search handles
@CathyEngMD
@PAscierto
@anup_kasi
@benweinbergmd
@clacardone
@doctorC369
@montypal
@rbryanbell
Search handles
@CathyEngMD
@PAscierto
@anup_kasi
@benweinbergmd
@clacardone
@doctorC369
@montypal
@rbryanbell
Filter by
Latest
over1year
5) The second day of Great Debates has started! The 1st debate is periphery/ blood Biomarker Vs TME Biomarker Prof @SamirNKhleif @Georgetown is arguing for TME/ argues ONLY APPROVED BIOMARKERS for IO are TME / talks PDL1 and #Immunoscore #bridge2022 @FondMelanoma @JeromeGalon ()
over 1 year ago
IO biomarker
|
PD-L1 (Programmed death ligand 1)
|
Immunoscore®
over1year
Results from a large patient cohort study @dkfz now provide a rare independent external validation of the #Immunoscore in #colorectalcancer. Very interesting results for MSS / Immunoscore high #CRC. Thanks to @jnkath and all collaborators. https://t.co/jRogOsjdli (@_mhoffmeister)
over 1 year ago
Clinical
|
Immunoscore®
over1year
Modified Immunoscore (mIS) incorporating CD3, CD8, CD45RO, FOXP3->digital pathology prognostic (for PFS) in EORTC high-risk Non–Muscle-Invasive #bladdercancer (but not in low/intermediate risk disease)-@Unispital_USZ @CPMS1B @UweBieri .https://t.co/csCYCzZpO9 @practiceupdate ()
over 1 year ago
CD8 (cluster of differentiation 8) • FOXP3 (Forkhead Box P3)
|
Immunoscore®
over1year
Study in #JCOPO from @FASinicropeMD et al. showing that immunoscore can refine prognosis beyond clinical risk group classification in stage III #coloncancer, suggesting its potential ability to inform decision making for adjuvant tx. ➡️ https://t.co/VuMN5Wfb8S #crcsm #biomarkers (@JCOPO_ASCO)
over 1 year ago
Clinical
|
Immunoscore®
over1year
👏Expanding tools to define prognosis of stage III #ColonCancer pts @JCOPO_ASCO https://t.co/7lfoeOmj3N ✅Immunoscore refines prognosis beyond clinical classification 👉5yrs Os btw 55% (High/TIL⬇️) & 92% (Low/TIL⬆️) 🧐Predictive utility needs to be defined @myESMO @OncoAlert ()
over 1 year ago
Clinical
|
Immunoscore®
over1year
Confirmation of the effectiveness of the Immunoscore in the prognostic accuracy of stage III colon cancer... ()
over 1 year ago
Immunoscore®
over1year
Big day with publication of two manuscripts; one showing Immunoscore can enhance prognostication with low and high T, N risk groups of stage 3 colon cancers. The other in Annals of Oncology showing that the association of TILs with survival differs by primary tumor sidedness. ()
over 1 year ago
Immunoscore®
almost2years
2) The @sitcancer #immunoscore taskforce built on work of @JeromeGalon & colleagues to validate the observations that pts with hi T cells infiltrating #coloncancer do better/live longer - More evidence imp role of immune system & #immunotherapy #Immune2cancer #FinishCancer ()
almost 2 years ago
Clinical
|
Immunoscore®
almost2years
Attending #WCGIC2022? Meet with our team at Booth #210 & don't miss Dr. @JeromeGalon's presentation on July 1 to learn more about how Veracyte's #Immunoscore may help guide treatment decisions by assessing the the patient's immune response in #ColonCancer https://t.co/aytrxggEk2 ()
almost 2 years ago
Clinical
|
Immunoscore®
almost2years
New data on the usefulness of #Immunoscore IC as an immune biomarker in metastatic #NSCLC and #CRC to be presented by Dr. @JeromeGalon at the 5th Annual @marketsmarkets Next Gen Immuno-Oncology Conference, Friday June 24, 2022, 11:15 - 11:45 a.m. EDT ()
almost 2 years ago
IO biomarker
|
Immunoscore® • Immunoscore® IC Assay
almost2years
Yes! Very much appreciate taking immunotherapy into earlier lines for MSI rectal cancer... As has been done in MANY other tumor types. Next up MSI colon cancer? Early Stage MSI with high immunoscore and risk w/ chemo? ()
almost 2 years ago
Immunoscore®
almost2years
Why "move on"? The three trials for MSI rectal cancer patients have not fully enrolled. And MSI colon cancer patients don't have immunotherapy options (even if older & immunoscore may make chemo riskier). Moving I/O into earlier lines could help also help the MSS pts... 1/2 ()
almost 2 years ago
Clinical
|
Immunoscore®
almost2years
I totally agree, these results are encouraging but they do not solve all the problems we have with stage II colon cancer. And they should be compared to other tools such as Immunoscore. ()
almost 2 years ago
Immunoscore®
almost2years
🎙Now out in @TheLancetOncol: AtezoTRIBE RCT on FOLFOXIRI/bev & atezo in #crcsm 👩🏻🏫Promising strategy for pMMR 👩🏻💻Immunoscore IC by @JeromeGalon as predictor to select immune hot tumors 💞Tnx @ChiaraCrem1 @FilippoPietran4 @LisaSalvy @SaraLonardi1 & patients https://t.co/iHdE3pPNzO ()
almost 2 years ago
Clinical
|
Immunoscore®
|
Tecentriq (atezolizumab) • 5-fluorouracil • oxaliplatin • leucovorin calcium
2years
#ImmunoScore terms are used often by a lot of papers to mean a lot of things. For #colorectalcancer #CRCSM @FASinicropeMD @TheLancet had the initial validation paper. 📝 @CCR_AACR https://t.co/3H5yduI950 #GI22 There’s some good information @CCAlliance. https://t.co/bC31iCCGeP ()
2 years ago
Immunoscore®
over2years
Personally, I send ctDNA (signatera) AND immunoscore for patients with stage II colon cancer and don't recommend adjuvant unless ctDNA+ or immunoscore low (@benweinbergmd)
over 2 years ago
Clinical • Circulating tumor DNA
|
Signatera™ • Immunoscore®
over2years
Prof @JeromeGalon #IMMUNOSCORE ROCKSTAR @Univ_Paris #INSERM reviews importance of identifying immune infiltrates in cancer & reports high immunoscore in #rectal cancer may identify patients that don’t require surgery/reports no recurrence @FondMelanoma #IOBridge2021 @PAscierto (@BernardAFox)
over 2 years ago
Clinical
|
Immunoscore®
over2years
TNM-I derived by integrating Immunoscore to TNM based stage II colon cancer, has the potential to guide adjuvant therapy decision making process for oncologists #CRCSM (@anup_kasi)
over 2 years ago
Clinical
|
Immunoscore®
over2years
Hot off the 🖨! New data published today in special article of Cancers!Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician Survey https://t.co/IzGGBB2go1 #mdpicancers via @Cancers_MDPI @manjuggm @efratdotan @anup_kasi @Dr_AfsanehBarzi (@GmanTheSciGuy)
over 2 years ago
Clinical
|
Immunoscore®
over2years
TNM-I derived by integrating Immunoscore to TNM based stage II colon cancer, has the potential to guide adjuvant therapy decision making process for oncologists #CRCSM (@anup_kasi)
over 2 years ago
Clinical
|
Immunoscore®
over2years
Fantastic discussion with @JeromeGalon on the cancer-immune contexture, immune escape mechanisms, and Immunoscore®! @EORTC #EORTC21 #LYMsm #Lymphoma #NHLsm #LYMsm (@VJHemOnc)
over 2 years ago
Immunoscore®
over2years
ICYMI: @JeromeGalon (@Inserm) just discussed the value of a diagnostic biopsy-adapted #immunoscore for predicting response to neoadjuvant treatment in #rectalcancer at #AACRtii21. For more, read the full study in @CCR_AACR. https://t.co/nSOsL126fT (@JBrosnanCashman)
over 2 years ago
Clinical
|
Immunoscore®
over2years
Discover how #Immunoscore can help you take charge of your #ColonCancer care with Graham Poage, Ph.D., @HalioDx medical science liaison director, and @benweinbergmd GI Oncologist @Georgetown @RueschCenter #PrecisionMedicine @GmanTheSciGuy https://t.co/XqgXwafv25 (@HalioDx)
over 2 years ago
Immunoscore®
over2years
Role of the #ImmuneResponse in the management of #ColorectalCancers was in focus at the #WorldGI2021. See Dr #MarjaneLeBagousse video presentation to discover how #Immunoscore is used as a #precisionmedicine tool in the management of patients https://t.co/tM3P6o1XkC (@HalioDx)
over 2 years ago
Video • Clinical
|
Immunoscore®
almost3years
I envision a day when a group of biomarkers together will have close to 100% sensitivity and specificity in resected early-stage colon cancer. What those would be- probably T4, N2, CDX2, MSI,ctDNA, IMMUNOSCORE…add your thoughts here. (@doctorC369)
almost 3 years ago
Circulating tumor DNA
|
CDX2 (Caudal Type Homeobox 2)
|
Immunoscore®
almost3years
@JeromeGalon talk on #Immunoscore at #WorldGI2021 Immune response assessment, a novel paradigm in #PrecisionOncology advised by @WHO for pathology reports and by @myESMO #ClinicalGuidelines to refine TNM staging to help adjust the chemotherapy decision in localized #ColonCancer (@HalioDx)
almost 3 years ago
Clinical guideline • Clinical
|
Immunoscore®
almost3years
@JeromeGalon at #WorldGI2021. With #Immunoscore, the assessment of tumor microenvironnement provides broader consideration of tumor features and body immune assets.This stable and safe test is enabled to be used in routine #ClinicalManagement for stage II and III #ColonCancer (@HalioDx)
almost 3 years ago
Clinical
|
Immunoscore®
almost3years
Don't miss @JeromeGalon presentation on #Immunoscore at #WorldGI2021! He will give a talk today at 11:10 AM (CEST) during Colloquium 2 "Molecular Marker Platforms: #PrecisionMedicine Development in #GastrointestinalOncology". See program: https://t.co/Z2cfNx9yw6 @myESMO @WCGIC (@HalioDx)
almost 3 years ago
Immunoscore®
almost3years
" #Immunoscore a new tool for #CRC #MolecularDiagnostics " to be presented by @JeromeGalon at Sharing Progress in Cancer Care (SPCC) webinar "Best practices/state-of-the-art in precision testing in #ColorectalCancer " ⏲️May 10 2021, 6 PM CEST https://t.co/O2jn9oMyh7 @ESOncology (@HalioDx)
almost 3 years ago
Immunoscore®
3years
@JeromeGalon and coauthors discuss the usefulness of #Immunoscore and biopsies-adapted #Immunoscore for prediction of clinical outcome and treatment response in #ColonCancer & #RectalCancer https://t.co/CXHbjBSgmt via @MDPIOpenAccess #ColorectalCancer #PrecisionMedicine (@HalioDx)
3 years ago
Clinical data • Clinical
|
Immunoscore®
3years
💥#immunoscore Guru @JeromeGalon @SorbonneParis1 @Univ_Paris @HalioDx /Immunoscore ID’d as essential-desirable criteria (@WHO) & included in clinical practice guidelines (@myESMO)/Validation of @sitcancer led global project/ #colorectalcancer/ @cncurtis asked great ?s #AACR2021 (@BernardAFox)
3 years ago
Clinical guideline • Clinical
|
Immunoscore®
3years
@JeromeGalon presented great data showing changes in #immune #microenvironment drive metastasis in multiple cancers including lung squamous cell carcinoma. He also discussed how Immunoscore based on context can predict prognosis and tumor progression @AACR, #AACR21, @lcrf_org (@EugeneManley)
3 years ago
Immunoscore®
3years
Viewpoint by @FASinicropeMD & @rondell_graham @MayoClinic pointing up interest of #TumorInfiltratingLymphocytes assessment for prognostication in #ColorectalCancer & clinical utility of #Immunoscore in early stage #ColonCancer to guide #treatmentdecision. #PrecisionMedicine (@HalioDx)
3 years ago
Clinical
|
Immunoscore®
3years
Use of CtDNA to monitor response to IO? Immunoscore test to predict response? @pashtoonkasi #GDUGI2021 #GreatDebatesGI #crcsm (@manjuggm)
3 years ago
Immunoscore®
3years
#Personalizedmedicine is becoming a reality thanks to technologies like #immunoscore developped by @HalioDx @ASCO Names Molecular Profiling in #GICancers as Advance of the Year https://t.co/v5DVChcJ8E via @onclive (@Immunopole)
3 years ago
Immunoscore®
over3years
@JeromeGalon at #GI21: Similar to the findings on IDEA France #Immunoscore study, significant #clinicalbenefit of #adjuvantchemotherapy is only observed for #Immunoscore High patients with #StageIIIColonCancer #PrecisionMedicine #BernhardMlecnik @JCO_ASCO https://t.co/FZCzPgTqcQ (@HalioDx)
over 3 years ago
Clinical
|
Immunoscore®
over3years
We're looking forward to hearing from @JeromeGalon at @ASCO #GI21 on immune-based assays for precision care. Watch him talk to @VJOncology about cancer risk quantification using the immunoscore assay: https://t.co/t4bmVKkUtY #Gism @OncoAlert #OncoAlert (@VJOncology)
over 3 years ago
Immunoscore®
over3years
The #Immunoscore presentation will start soon, don’t miss it! @JeromeGalon will present #ImmuneBased Assays at #GI21 (@ASCO #Gastrointestinal Cancers Symposium) during the session "Emerging Tools for #PrecisionCare https://t.co/nhaKxoIYPk #ASCOGI #colorectalcancer #oncology (@HalioDx)
over 3 years ago
Immunoscore®
over3years
Do not miss presentation by @JeromeGalon at #GI21 (@ASCO 2021 #Gastrointestinal Cancers Symposium) on #ImmuneBased Assays during the session "Emerging Tools for #PrecisionCare" (January 16, 7:15-8:15 PM CET) https://t.co/R1d5zU1Uo0 #ASCOGI #Immunoscore #colorectalcancer #oncology (@HalioDx)
over 3 years ago
Immunoscore®
over3years
Do not miss presentation by @JeromeGalon at #GI21 (@ASCO 2021 #Gastrointestinal Cancers Symposium) on #ImmuneBased Assays during the session "Emerging Tools for #PrecisionCare" (January 16, 7:15-8:15 PM CET) https://t.co/pc6VbUXR0r #ASCOGI #Immunoscore #colorectalcancer #oncology (@HalioDx)
over 3 years ago
Immunoscore®
over3years
"Day 2 of #Bridge20 has started/Prof @JeromeGalon #immunoscore Pioneer & #TME Rockstar opens session/impact Germline genetic contrib to immunoscore & Imm hi pts whether tu regress or not, hi do better than low/ @FondMelanoma @HalioDx @Oncoinfo_it @AkoyaBio @Ultivue #ColonCancer" (@BernardAFox)
over 3 years ago
Clinical
|
Immunoscore®
over3years
Performance of #Immunoscore in Asian Patients With Early-Stage #ColonCancer - The ASCO Post @asco @JeromeGalon https://t.co/uOqMOjY6Lt (@HalioDx)
over 3 years ago
Clinical
|
Immunoscore®
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login